Literature DB >> 18367292

Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.

Kana Kitamura1, Hideo Asada, Hideyuki Iida, Takaya Fukumoto, Nobuhiko Kobayashi, Hironori Niizeki, Takeshi Morii, Hiroshi Kimura, Sachiko Miyagawa.   

Abstract

BACKGROUND: The relationship between herpesvirus reactivation and graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-SCT) is unclear.
OBJECTIVE: We sought to examine the relationship between human herpesvirus (HHV) reactivation and rash/GVHD after allo-SCT by prospective evaluation.
METHODS: Fifteen patients who had received allo-SCT underwent prospective serial examinations for human herpesvirus 6 (HHV-6), HHV-7, cytomegalovirus, and Epstein-Barr virus DNA in the blood by polymerase chain reaction and real-time polymerase chain reaction. Serum interferon gamma, interleukins 4 and 10, tumor necrosis factor alpha, and soluble interleukin 2 receptor (sIL-2R) were also measured.
RESULTS: In 10 of 15 patients, macular/papular eruptions were seen after allo-SCT and GVHD was diagnosed. In 8 patients with rash, HHV-6 DNA levels correlated with the cutaneous manifestation. Interleukin 10 and sIL-2R also increased in association with rash. LIMITATIONS: The number of patients in our study was relatively small. Not all patients were examined for cytokines and sIL-2R.
CONCLUSIONS: HHV-6 reactivation may be involved in the pathogenesis of rash/GVHD after allo-SCT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367292     DOI: 10.1016/j.jaad.2008.01.005

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

Review 1.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

2.  Inpatient Management of Mucocutaneous GVHD.

Authors:  Toral Vaidya; Christian Menzer; Doris M Ponce; Alina Markova
Journal:  Curr Dermatol Rep       Date:  2019-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.